{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:18:35Z","timestamp":1782602315395,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T00:00:00Z","timestamp":1457913600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s40292-016-0136-5","type":"journal-article","created":{"date-parts":[[2016,3,14]],"date-time":"2016-03-14T09:33:36Z","timestamp":1457948016000},"page":"69-72","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hyperaldosteronism: Screening and Diagnostic Tests"],"prefix":"10.1007","volume":"23","author":[{"given":"Chiara","family":"Sabbadin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Fallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,3,14]]},"reference":[{"issue":"8","key":"136_CR1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","volume":"45","author":"P Milliez","year":"2005","unstructured":"Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence of an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol. 2005;45(8):1243\u20138.","journal-title":"J Am Coll Cardiol."},{"issue":"2","key":"136_CR2","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s11906-007-0019-1","volume":"9","author":"F Fallo","year":"2007","unstructured":"Fallo F, Federspil G, Veglio F, Mulatero P. The metabolic syndrome in primary aldosteronism. Curr Hypertens Rep. 2007;9(2):106\u201311.","journal-title":"Curr Hypertens Rep."},{"issue":"12","key":"136_CR3","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","volume":"98","author":"P Mulatero","year":"2013","unstructured":"Mulatero P, Monticone S, Bertello C, Viola A, Tiziani D, Iannaccone A, Crudo V, Burrello J, Milan A, Rabbia F, Veglio F. Long-term cardio- and cerebrovascular events in patients with primary aldosteronism. J Clin Endocrinol Metab. 2013;98(12):4826\u201333.","journal-title":"J Clin Endocrinol Metab."},{"issue":"9","key":"136_CR4","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","volume":"93","author":"JW Funder","year":"2008","unstructured":"Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, Young WF Jr, Montori VM, Endocrine Society. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93(9):3266\u201381.","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"136_CR5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1161\/01.HYP.0000079505.25750.11","volume":"42","author":"L Mosso","year":"2003","unstructured":"Mosso L, Carvajal C, Gonz\u00e0lez A, Barraza A, Avila F, Montero J, Huete A, Gederlini A, Fardella CE. Primary aldosteronism and hypertensive disease. Hypertension. 2003;42(2):161\u20135.","journal-title":"Hypertension"},{"issue":"6","key":"136_CR6","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","volume":"40","author":"DA Calhoun","year":"2002","unstructured":"Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P. Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension. 2002;40(6):892\u20136.","journal-title":"Hypertension"},{"issue":"11","key":"136_CR7","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","volume":"48","author":"GP Rossi","year":"2006","unstructured":"Rossi GP, Bernini G, Caliumi C, Desideri G, Fabris B, Ferri C, Ganzaroli C, Giacchetti G, Letizia C, Maccario M, Mallamaci F, Mannelli M, Mattarello MJ, Moretti A, Palumbo G, Parenti G, Porteri E, Semplicini A, Rizzoni D, Rossi E, Boscaro M, Pessina AC, Mantero F, PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol. 2006;48(11):2293\u2013300.","journal-title":"J Am Coll Cardiol."},{"key":"136_CR8","unstructured":"Mantero F, Terzolo M, Arnaldi G, Osella G, Masini AM, Giovagnetti M, Opocher G, Angeli A. A survey on adrenal incidentaloma in Italy. Study Group on Adrenal Tumors of the Italian Society of Endocrinology. J Clin Endocrinol Metab. 2000;85(2):637\u201344."},{"issue":"2","key":"136_CR9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2165\/00151642-200714020-00004","volume":"14","author":"M Stowasser","year":"2007","unstructured":"Stowasser M, Fallo F, So A, Jeske Y, Kelemen L, Pilon C, Gordon R. Genetic forms of primary aldosteronism. High Blood Press Cardiovasc Prev. 2007;14(2):75\u201381.","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"136_CR10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.mce.2014.09.015","volume":"399","author":"S Monticone","year":"2015","unstructured":"Monticone S, Else T, Mulatero P, Williams TA, Rainey WR. Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol Cell Endocrinol. 2015;399:311\u201320.","journal-title":"Mol Cell Endocrinol."},{"issue":"21","key":"136_CR11","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1056\/NEJM196511182732106","volume":"273","author":"JW Conn","year":"1965","unstructured":"Conn JW. Hypertension, the potassium ion and impaired carbohydrate tolerance. N Engl J Med. 1965;273(21):1135\u201343.","journal-title":"N Engl J Med"},{"issue":"2","key":"136_CR12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","volume":"91","author":"F Fallo","year":"2006","unstructured":"Fallo F, Veglio F, Bertello C, Sonino N, Della Mea P, Ermani M, Rabbia F, Federspil G, Mulatero P. Prevalence and characteristics of the metabolic syndrome in primary aldosteronism. J Clin Endocrinol Metab. 2006;91(2):454\u20139.","journal-title":"J Clin Endocrinol Metab."},{"issue":"5","key":"136_CR13","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","volume":"173","author":"G Hanslik","year":"2015","unstructured":"Hanslik G, Wallaschofski H, Dietz A, Riester A, Reincke M, Allolio B, Lang K, Quack I, Rump LC, Willenberg HS, Beuschlein F, Quinkler M, Hannemann A, Participants of the German Conn\u2019s Registry. Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn\u2019s Registry. Eur J Endocrinol. 2015;173(5):665\u201375.","journal-title":"Eur J Endocrinol."},{"issue":"5","key":"136_CR14","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jc.2009-2204","volume":"95","author":"G Iacobellis","year":"2010","unstructured":"Iacobellis G, Petramala L, Cotesta D, Pergolini M, Zinnamosca L, Cianci R, De Toma G, Sciomer S, Letizia C. Adipokines and cardiometabolic profile in primary hypealdosteronism. J Clin Endocrinol Metab. 2010;95(5):2391\u20138.","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"136_CR15","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","volume":"44","author":"F Fallo","year":"2012","unstructured":"Fallo F, Pilon C, Urbanet R. Primary aldosteronism and metabolic syndrome. Horm Metab Res. 2012;44(3):208\u201314.","journal-title":"Horm Metab Res."},{"issue":"10","key":"136_CR16","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1097\/HJH.0000000000000284","volume":"32","author":"L Petramala","year":"2014","unstructured":"Petramala L, Pignatelli P, Carnevale R, Zinnamosca L, Marinelli C, Settevendemmie A, Concistr\u00e8 A, Tonnarini G, De Toma G, Violi F, Letizia C. Oxidative stress in patients affected by primary aldosteronism. J Hypertens. 2014;32(10):2022\u20139.","journal-title":"J Hypertens."},{"issue":"2","key":"136_CR17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.06-1442","volume":"131","author":"M Pratt-Ubunama","year":"2007","unstructured":"Pratt-Ubunama M, Nishizaka MK, Boedefeld RL, Cofield SS, Harding SM, Calhoun DA. Plasma aldosterone is related to severity of obstructive sleep apnea in subjects with resistant hypertension. Chest. 2007;131(2):453\u20139.","journal-title":"Chest"},{"issue":"8","key":"136_CR18","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/jhh.2009.96","volume":"24","author":"K Gaddam","year":"2010","unstructured":"Gaddam K, Pimenta E, Thomas SJ, Cofield SS, Oparil S, Harding SM, Calhoun DA. Spironolactone reduces severity of obstructive sleep apnea in patients with resistant hypertension: a preliminary report. J Hum Hypertens. 2010;24(8):532\u20137.","journal-title":"J Hum Hypertens."},{"issue":"3","key":"136_CR19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1177\/1470320310366581","volume":"11","author":"A Murro Di","year":"2010","unstructured":"Di Murro A, Petramala L, Cotesta D, Zinnamosca L, Crescenzi E, Marinelli C, Saponara M, Letizia C. Renin\u2013angiotensin\u2013aldosterone system in patients with sleep apnoea: prevalence of primary aldosteronism. J Renin Angiotensin Aldosterone Syst. 2010;11(3):165\u201372.","journal-title":"J Renin Angiotensin Aldosterone Syst."},{"issue":"12","key":"136_CR20","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1097\/HJH.0000000000000727","volume":"33","author":"J Manolopoulou","year":"2015","unstructured":"Manolopoulou J, Fischer E, Dietz A, Diederich S, Holmes D, Junnila R, Grimminger P, Reincke M, Morganti A, Bidlingmaier M. Clinical validation for the aldosterone-to-renin ratio and aldosterone suppression testing using simultaneous fully automated chemiluminescence immunoassays. J Hypertens. 2015;33(12):2500\u201311.","journal-title":"J Hypertens."},{"issue":"6","key":"136_CR21","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1055\/s-0029-1246186","volume":"42","author":"P Mulatero","year":"2010","unstructured":"Mulatero P, Monticone S, Bertello C, Mengozzi G, Tizzani D, Iannaccone A, Crudo V, Veglio F. Confirmatory tests in the diagnosis of primary aldosteronism. Horm Metab Res. 2010;42(6):406\u201310.","journal-title":"Horm Metab Res"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-016-0136-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40292-016-0136-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-016-0136-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T22:23:50Z","timestamp":1559514230000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40292-016-0136-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3,14]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["136"],"URL":"https:\/\/doi.org\/10.1007\/s40292-016-0136-5","relation":{},"ISSN":["1120-9879","1179-1985"],"issn-type":[{"value":"1120-9879","type":"print"},{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,3,14]]}}}